Wire · opportunities
MiniMed Wins FDA Clearance for Fit, Its First Tubeless Insulin Pump
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 16 November 2026 · Fusion42 review
MiniMed has received FDA clearance for its MiniMed Fit, a tubeless insulin pump featuring up to seven days of wear, 300-unit insulin capacity, app control, and SmartGuard automated insulin delivery technology, marking an expansion into a segment long dominated by competitors. The device aims to enhance convenience and clinical performance for people with diabetes and will be available through the pharmacy channel, with a phased U.S. rollout expected in spring 2027.
This Wire brief sits within Fusion42's coverage of Medtech, and 3 sources have reported it between 16 Nov 2026 and 17 Nov 2026.
◆ ◆ The Wire takeaway
MiniMed's FDA clearance opens pharmacy distribution for tubeless insulin pumps, shifting access and competition in diabetes care technology. You need to explore integrating app-driven automated insulin delivery with pharmacy channels to capture this newly accessible market segment.
◆ Coverage
3 sources · first reported 16 Nov 2026 · latest 17 Nov 2026
◆ Related on Wire
◆ Topics